GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (TSX:APS) » Definitions » E10

Aptose Biosciences (TSX:APS) E10 : C$-458.81 (As of Sep. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Aptose Biosciences E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Aptose Biosciences's adjusted earnings per share data for the three months ended in Sep. 2024 was C$-15.036. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is C$-458.81 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was 8.60% per year. During the past 5 years, the average E10 Growth Rate was 7.80% per year. During the past 10 years, the average E10 Growth Rate was 24.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Aptose Biosciences was 40.40% per year. The lowest was 3.50% per year. And the median was 18.15% per year.

As of today (2025-03-17), Aptose Biosciences's current stock price is C$5.22. Aptose Biosciences's E10 for the quarter that ended in Sep. 2024 was C$-458.81. Aptose Biosciences's Shiller PE Ratio of today is .


Aptose Biosciences E10 Historical Data

The historical data trend for Aptose Biosciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptose Biosciences E10 Chart

Aptose Biosciences Annual Data
Trend May14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -910.09 -712.34 -647.51 -581.56 -543.42

Aptose Biosciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -556.33 -543.42 -508.97 -487.25 -458.81

Competitive Comparison of Aptose Biosciences's E10

For the Biotechnology subindustry, Aptose Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptose Biosciences's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptose Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Aptose Biosciences's Shiller PE Ratio falls into.



Aptose Biosciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Aptose Biosciences's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-15.036/127.2847*127.2847
=-15.036

Current CPI (Sep. 2024) = 127.2847.

Aptose Biosciences Quarterly Data

per share eps CPI Adj_EPS
201409 0.000 99.394 0.000
201503 -134.361 99.789 -171.382
201506 -125.512 100.500 -158.962
201509 -120.061 100.421 -152.178
201512 -168.980 99.947 -215.199
201603 -192.576 101.054 -242.564
201606 -206.299 102.002 -257.434
201609 -139.905 101.765 -174.990
201612 -116.112 101.449 -145.683
201703 -114.459 102.634 -141.950
201706 -65.810 103.029 -81.304
201709 -60.781 103.345 -74.861
201712 -68.953 103.345 -84.926
201803 -133.857 105.004 -162.260
201806 -177.188 105.557 -213.660
201809 -93.845 105.636 -113.077
201812 -90.693 105.399 -109.525
201903 -84.237 106.979 -100.226
201906 -77.741 107.690 -91.886
201909 -71.501 107.611 -84.573
201912 -77.039 107.769 -90.990
202003 -94.230 107.927 -111.131
202006 -128.066 108.401 -150.375
202009 -89.303 108.164 -105.089
202012 -92.225 108.559 -108.133
202103 -101.809 110.298 -117.489
202106 -82.485 111.720 -93.977
202109 -74.125 112.905 -83.566
202112 -155.520 113.774 -173.988
202203 -68.364 117.646 -73.965
202206 -66.069 120.806 -69.612
202209 -63.627 120.648 -67.127
202212 -66.431 120.964 -69.902
202303 -91.129 122.702 -94.532
202306 -90.478 124.203 -92.723
202309 -71.444 125.230 -72.616
202312 -57.957 125.072 -58.982
202403 -29.644 126.258 -29.885
202406 -17.679 127.522 -17.646
202409 -15.036 127.285 -15.036

Add all the adjusted EPS together and divide 10 will get our e10.


Aptose Biosciences  (TSX:APS) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Aptose Biosciences E10 Related Terms

Thank you for viewing the detailed overview of Aptose Biosciences's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptose Biosciences Business Description

Traded in Other Exchanges
Address
251 Consumers Road, Suite 1105, Toronto, ON, CAN, M2J 4R3
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.
Executives
Bernd Robert Seizinger Director
William Glenn Rice Director, Senior Officer
Erich Platzer Director
Rafael Bejar Senior Officer
Warren Whitehead Director
Gregory Kwok Lee Chow Senior Officer
Jotin Marango Senior Officer

Aptose Biosciences Headlines

No Headlines